Target intelligence / Profile preview

RNA, 5S ribosomal pseudogene 265 (RNA5SP265)

Target
RNA5SP265
Molecular classification
Other (pseudogene)
01

Overview

RNA, 5S ribosomal pseudogene 265 is a **nonfunctional genetic element** in the human genome related to the 5S ribosomal RNA gene. Pseudogenes such as RNA5SP265 resemble true protein- or RNA-coding genes but contain disabling mutations or lack regulatory elements required for expression, and thus do not produce functional products[2][6]. The canonical 5S rRNA gene is essential for assembling the large ribosomal subunit and protein synthesis[1][5], but pseudogenes like RNA5SP265 are generally considered *genomic fossils* without a known biological or disease-modifying role. There is no evidence that RNA5SP265 acts as a receptor, enzyme, or therapeutic target, nor is it implicated as a clinically relevant biomarker or drug-interaction partner. The entry “RNA, 5S ribosomal pseudogene 265” is **not** a protein, receptor, enzyme, or molecular target in the conventional sense. Pseudogenes can occasionally play indirect regulatory roles (e.g., as competitive endogenous RNAs in some cancers)[4][6], but there is no published evidence of such a function for this specific gene.

Other names
RNA5SP265RN5S265RNA, 5S ribosomal 265RNA, 5S ribosomal pseudogene 265
02

Mechanism of action

None (not a drug target)

03

Biological functions

None (no direct biological function; pseudogenes generally do not encode functional products)
04

Disease associations

Other (pseudogenes can occasionally be used as markers in molecular studies, but there is no evidence that RNA5SP265 has disease relevance)
05

Safety considerations

None (not targeted, so no safety concerns are reported)
06

Interacting drugs

None (no drugs target this pseudogene)
07

Biomarkers

None (no evidence for use as clinical biomarker)

Beyond the preview

Go deeper on RNA, 5S ribosomal pseudogene 265 (RNA5SP265).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 5S ribosomal pseudogene 265 (RNA5SP265).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call